Undalig, Baby Boy P.
HRN: 29-33-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
CEFUROXIME 750MG (VIAL)
07/20/2026
07/27/2026
IV
250MG
Q8
PCAP C
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes